BR112023006154A2 - Cápsulas softgel de liberação modificada - Google Patents
Cápsulas softgel de liberação modificadaInfo
- Publication number
- BR112023006154A2 BR112023006154A2 BR112023006154A BR112023006154A BR112023006154A2 BR 112023006154 A2 BR112023006154 A2 BR 112023006154A2 BR 112023006154 A BR112023006154 A BR 112023006154A BR 112023006154 A BR112023006154 A BR 112023006154A BR 112023006154 A2 BR112023006154 A2 BR 112023006154A2
- Authority
- BR
- Brazil
- Prior art keywords
- release
- dependent
- softgel capsules
- capsules
- modified release
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title abstract 4
- 230000001419 dependent effect Effects 0.000 abstract 4
- 238000013270 controlled release Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063092762P | 2020-10-16 | 2020-10-16 | |
| PCT/US2021/071900 WO2022082222A1 (en) | 2020-10-16 | 2021-10-15 | Modified release softgel capsules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023006154A2 true BR112023006154A2 (pt) | 2023-05-09 |
Family
ID=81208677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023006154A BR112023006154A2 (pt) | 2020-10-16 | 2021-10-15 | Cápsulas softgel de liberação modificada |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230390210A1 (https=) |
| EP (1) | EP4228597A4 (https=) |
| JP (1) | JP2023547062A (https=) |
| KR (1) | KR20230088388A (https=) |
| CN (1) | CN116322655A (https=) |
| AR (1) | AR123805A1 (https=) |
| AU (1) | AU2021362248A1 (https=) |
| BR (1) | BR112023006154A2 (https=) |
| CA (1) | CA3194160A1 (https=) |
| CO (1) | CO2023005753A2 (https=) |
| IL (1) | IL301715A (https=) |
| MX (1) | MX2023004418A (https=) |
| TW (1) | TW202228656A (https=) |
| WO (1) | WO2022082222A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025135085A1 (ja) * | 2023-12-22 | 2025-06-26 | 花王株式会社 | カプセル剤 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4708834A (en) * | 1986-05-01 | 1987-11-24 | Pharmacaps, Inc. | Preparation of gelatin-encapsulated controlled release composition |
| US7842307B2 (en) * | 2001-08-06 | 2010-11-30 | Purdue Pharma L.P. | Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent |
| DE60238269D1 (de) * | 2001-11-22 | 2010-12-23 | Morishita Jintan Co | Nicht-gelatinöse Kapseln |
| KR100575199B1 (ko) * | 2003-01-24 | 2006-05-02 | 알앤피코리아주식회사 | 연질 캡슐의 블루밍 방지를 위한 가소제 조성물 및 이를함유한 피막 |
| IT1401313B1 (it) * | 2010-08-05 | 2013-07-18 | Perfetti Van Melle Spa | Caramelle gelatinose con ripieno fluido e metodo di ottenimento |
| US20120301546A1 (en) * | 2011-05-26 | 2012-11-29 | Hassan Emadeldin M | Acid-resistant soft gel compositions |
| GB201304662D0 (en) * | 2013-03-14 | 2013-05-01 | Sigmoid Pharma Ltd | Compositions |
| GB201319792D0 (en) * | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| US20150366814A1 (en) * | 2014-06-23 | 2015-12-24 | Banner Life Sciences Llc | All-natural enteric soft capsules comprising active ingredients |
| US20170119680A1 (en) * | 2015-10-30 | 2017-05-04 | R.P. Scherer Technologies, Llc | Extended release film-coated capsules |
| AU2019362883B2 (en) * | 2018-10-16 | 2025-07-31 | Bayer Healthcare Llc | Softgels with solid or gel-like polymeric fill matrix |
| US20220400724A1 (en) * | 2019-10-28 | 2022-12-22 | R.P. Scherer Technologies, Llc | Delayed release softgel capsules in higher ph environment |
-
2021
- 2021-10-15 EP EP21881332.7A patent/EP4228597A4/en active Pending
- 2021-10-15 WO PCT/US2021/071900 patent/WO2022082222A1/en not_active Ceased
- 2021-10-15 CA CA3194160A patent/CA3194160A1/en active Pending
- 2021-10-15 CN CN202180070928.5A patent/CN116322655A/zh active Pending
- 2021-10-15 AR ARP210102856A patent/AR123805A1/es unknown
- 2021-10-15 MX MX2023004418A patent/MX2023004418A/es unknown
- 2021-10-15 US US18/031,669 patent/US20230390210A1/en active Pending
- 2021-10-15 IL IL301715A patent/IL301715A/en unknown
- 2021-10-15 AU AU2021362248A patent/AU2021362248A1/en active Pending
- 2021-10-15 JP JP2023523094A patent/JP2023547062A/ja active Pending
- 2021-10-15 KR KR1020237015684A patent/KR20230088388A/ko active Pending
- 2021-10-15 TW TW110138424A patent/TW202228656A/zh unknown
- 2021-10-15 BR BR112023006154A patent/BR112023006154A2/pt unknown
-
2023
- 2023-05-05 CO CONC2023/0005753A patent/CO2023005753A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN116322655A (zh) | 2023-06-23 |
| MX2023004418A (es) | 2023-05-04 |
| TW202228656A (zh) | 2022-08-01 |
| AR123805A1 (es) | 2023-01-11 |
| KR20230088388A (ko) | 2023-06-19 |
| WO2022082222A1 (en) | 2022-04-21 |
| AU2021362248A1 (en) | 2023-06-01 |
| AU2021362248A9 (en) | 2024-05-02 |
| CO2023005753A2 (es) | 2023-05-29 |
| EP4228597A1 (en) | 2023-08-23 |
| US20230390210A1 (en) | 2023-12-07 |
| JP2023547062A (ja) | 2023-11-09 |
| CA3194160A1 (en) | 2022-04-21 |
| IL301715A (en) | 2023-05-01 |
| EP4228597A4 (en) | 2024-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021024375A2 (pt) | Cápsulas de softgel de liberação retardada | |
| BR112012026223A2 (pt) | formulação adequada para o uso em ração animal, uso, e ração para animais. | |
| JP2014516082A (ja) | ガン細胞の増殖を阻害するアミド誘導体および非金属塩滑沢剤を含む医薬組成物 | |
| BR112013028453B8 (pt) | Uso de uma composição de revestimento, formas de dosagem farmacêuticas ou nutracêuticas gastrorresistentes, e composição do polímero do núcleo/invólucro | |
| KR20210152588A (ko) | 리나클로타이드의 지연 방출 조성물 | |
| BR112015000320A2 (pt) | composições farmacêuticas dissuasivas de abuso, de liberação prolongada | |
| BR112022009755A2 (pt) | Produto análogo à carne, e, método para a preparação de um produto análogo à carne | |
| BR112023006154A2 (pt) | Cápsulas softgel de liberação modificada | |
| BR112022012118A2 (pt) | Kit para preparar uma composição de nanopartículas | |
| RU2018140900A (ru) | Семаглутид при сердечно-сосудистых состояниях | |
| MX2023005451A (es) | Capsulas de gel blando de liberacion retardada. | |
| HRP20211361T1 (hr) | Kombinirana formulacija tezofenzina i metoprolola | |
| BR112015021630A2 (pt) | estabilização de fármacos sensíveis à umidade | |
| BR112017009510A2 (pt) | composições compreendendo ciclosporina | |
| KR20130004285A (ko) | 속방성 캡슐화 조성물 | |
| BR112022024391A2 (pt) | Cápsulas de gelatina mole para liberação retardada | |
| JP2015193635A (ja) | 速溶性防湿フィルムコーティング製剤及びその製造方法 | |
| EA201690768A1 (ru) | Состав, предотвращающий некротический энтерит у домашних птиц | |
| Kannan et al. | Formulation and evaluation of aspirin delayed release tablet | |
| EA201990704A1 (ru) | Составная капсула, содержащая эзомепразол, и способ ее получения | |
| BR112022025220A2 (pt) | Composição farmacêutica e artigo farmacêutico | |
| RU2018100755A (ru) | Комбинированный препарат мозаприда и рабепразола | |
| WO2018108939A3 (de) | Feste pharmazeutische orale darreichungsform mit verlängerter wirkstofffreisetzung umfassend mirabegron | |
| MX2025000556A (es) | Composiciones agricolas y metodos | |
| WO2016204657A3 (ru) | Способ получения фармацевтической композиции адеметионина и его лекарственной формы |